Invention Grant
US09334276B2 Forms and salts of a dihydropyrrolo[1,2c]imidazolyl aldosterone synthase or aromatase inhibitor
有权
二氢吡咯并[1,2c]咪唑基醛固酮合酶或芳香酶抑制剂的形式和盐
![Forms and salts of a dihydropyrrolo[1,2c]imidazolyl aldosterone synthase or aromatase inhibitor](/docs/US/2016-05-10/US09334276B2/abs.jpg.600x600.jpg)
- Patent Title: Forms and salts of a dihydropyrrolo[1,2c]imidazolyl aldosterone synthase or aromatase inhibitor
- Patent Title (中): 二氢吡咯并[1,2c]咪唑基醛固酮合酶或芳香酶抑制剂的形式和盐
-
Application No.: US14370124Application Date: 2013-01-15
-
Publication No.: US09334276B2Publication Date: 2016-05-10
- Inventor: Paul Allen Sutton , Eric Loeser
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Michelle Han
- International Application: PCT/US2013/021521 WO 20130115
- International Announcement: WO2013/109514 WO 20130725
- Main IPC: C07D487/04
- IPC: C07D487/04
![Forms and salts of a dihydropyrrolo[1,2c]imidazolyl aldosterone synthase or aromatase inhibitor](/abs-image/US/2016/05/10/US09334276B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to a phosphate salt or a nitrate salt of 4-(R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl-3-fluoro-benzonitrile, especially in crystalline form, and specific forms of these salts, as well as related invention embodiments. The salts and salt forms allow for the prophylactic and/or therapeutic treatment of aldosterone synthase and/or aromatase mediated diseases or disorders.
Public/Granted literature
- US20140364470A1 New forms and salts of a dihydropyrrolo[1,2c]imidazolyl aldosterone synthase or aromatase inhibitor Public/Granted day:2014-12-11
Information query
